Menglin Li

grad student

2013-

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Li ML, Peng Y, An Y, et al. (2022) LY395756 promotes NR2B expression via activation of AKT/CREB signaling in the juvenile methylazoxymethanol mice model of schizophrenia. Brain and Behavior. e2466
Gao W, Xing B, Li M, et al. (2019) 40.3 TARGETING NMDAR HYPOFUNCTION DURING EARLY DEVELOPMENT FOR THE PREVENTION OF SCHIZOPHRENIA PHENOTYPES IN ADULTHOOD IN THE MAM MODEL Schizophrenia Bulletin. 45: S154-S154
Li ML, Gulchina Y, Monaco SA, et al. (2017) Juvenile Treatment with a Novel mGluR2 Agonist/mGluR3 Antagonist Compound, LY395756, Reverses Learning Deficits and Cognitive Flexibility Impairments in Adults in A Neurodevelopmental Model of Schizophrenia. Neurobiology of Learning and Memory
Li ML, Yang SS, Xing B, et al. (2015) LY395756, an mGluR2 agonist and mGluR3 antagonist, enhances NMDA receptor expression and function in the normal adult rat prefrontal cortex, but fails to improve working memory and reverse MK801-induced working memory impairment. Experimental Neurology
Li ML, Hu XQ, Li F, et al. (2015) Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end? Progress in Neuro-Psychopharmacology & Biological Psychiatry. 60: 66-76